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ABSTRACT 
The calculation of an accurate dose of chemotherapy for oncological patients 
reduces the possible medication errors and the toxicity of the body and so it 
improves the outcome of the treatment (survival). In oncological practice for 
the calculation of the dose of chemotherapy the human body surface area 
(BSA) is used. The human body surface area is determined by derived formu-
las, but it is not directly linked to the pharmacokinetics of the drugs. Pharma-
cokinetic studies have demonstrated that for the calculation of the chemo-
therapy dose the actual body weight should be taken into account rather than 
the ideal one. In the therapeutic dose determination the body fat mass has 
essential significance. 
202 patients aged from 19 to 83 years with various tumor localizations 
underwent anthropometric measurements (height, weight, circumferences, fat-
fold thickness, the distance between the hills above the joint), the body mass 
index (BMI) and the BSA (according to the Mosteller formula).  
The average weight of 99 men was 78.5 ± 16.4 kg and the mean body weight 
of 103 women was 70.1 ± 14.6 kg, statistically non-significantly different   
(F = 0.358, p = 0.551), but the independent-sample t-test arithmetical mean 
differed statistically significantly (t = 3.839, p <0.001). The oncological patients   Anthropometric measurements of the body composition ...  |  57 
in the absolute and relative distribution of groups according to the body mass 
index in relation to the patients gender differed statistically significantly (χ2 = 
11.510, df = 4, p = 0.021). Half of the men had ideal weight (body mass), but 
only about 1/3 of women were with the ideal body weight. The men’s average 
body mass index was 25.41 ± 4.73 kg/m2 and the women’s average body mass 
index was 26.20 ± 5.90 kg/m . After arithmetic calculation of the body surface  2
area using a variety of formulas, men’s BSA differs less than 1% compared to the 
calculated area of Mosteller formula. For women the differences are more 
than 1%. Distribution of patients in groups body fat content (%) of the patient’s 
shows that male and female patients were primarily from the group with 
excessive fat in the body, the body fat for men is 25% or more of the total body 
weight, but for the women it is over 32% of the total body weight. Correlation 
analysis showed that the body fat for men correlates with the body surface area, 
calculated using the Mosteller formula (r = 0.663, p <0.001) and the fat content 
for women correlates with the body surface area, calculated using the Mosteller 
formula (r = 0.760, p <0.001). The male body volume of the mean value was 
75, 0 ± 17.1 dm3, the female body volume of the mean value was 68,   
6 ± 15.6 dm3. After the independent samples t-test between men and women in 
body volume arithmetical means differed statistically significantly (t = 2.437,  
p = 0.016). 
Anthropometric measurements are suitable for the calculation of the doses 
of chemotherapy, but taking into account the correlation, it cannot be excluded 
that they reflect the same body surface area. The BMI does not feature the 
percentage of the fat mass of the whole body. Consequently, it is possible that 
the patient’s body density is a more physiological parameter, which could be 
determined for comparison by using abdominal computer tomography. The 
body volume index(BVI) could be one of the most recent parameters for the 
more accurate calculation of chemotherapy for cancer patients. The Body 
Volume Index (BVI) is a new measurement for human obesity that has been 
proposed as an alternative to the Body Mass Index (BMI). 
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INTRODUCTION 
Individualsʼ response to receiving chemotherapy can be very different, with 
significant clinical implications. A successful chemotherapy program develops 
a consistent therapeutic effect minimizing normal tissue toxicity. A fixed-dose 
chemotherapy reduces the calculation of potential medication errors [6]. 58  |  A. Gerina-Berzina, U. Vikmanis, U. Teibe, S. Umbrashko 
Chemotherapy dose calculation is using the human body surface area(BSA). 
For the BSA calculation different derived formulas are used. The means of the 
measurement of patients of different ages, shapes and sizes a formula for 
calculating the surface area using weight and height was first derived in 
1916(DuBois and DuBois) [4]. The surface area has been defined by a 
concept, that it is variable with difficult reproductive assessments. Currently, 
several institutions are using the Du Bois formula. There are several arguments 
for and against the Du Bois formula used to calculate body surface area. The 
fact that the nine subjects who were assessed had different body shapes is in 
favor of the Du Bois formula. However, many researchers have questioned the 
accuracy of the formula. In the results of the study, Jones and his colleagues 
[10] have shown that this equation is not the most accurate, because the Du 
Bois and Du Bois formula estimate only one leg and arm assuming that the 
body is symmetrical. But this assumption cannot be applied to people with 
disabilities [2], as well as the formula greatly overestimates the surface area of 
the people who are overweight (obese). The above-described results were 
supported by Wand and his colleagues in 1992. Since the Du Bois formula was 
derived from a small number of individual measurements, where some of them 
had skeletal deformities and only one child was included, the question of the 
reasonableness and accuracy of the formula for babies, people with excess body 
(pregnancy, obesity, high height) was raised. The Du Bois formula accuracy 
was evaluated using the predictive mean squared error (RMSE interpreters. 
Vkk) method. RMSE is the degree of correlation between the measured and 
the expected data because the Du Bois formula systematically underestimates 
the BSA (body surface area) by almost 5%. After the RMSE methods there are 
about 15 different formulas to predict the BSA, 8 is the RMSE of less than 8%. 
The Du Bois formula ranks fifth on the lowest RMSE. Nevertheless, the Du 
Bois formula continues to be used, probably more than a tradition of precision 
and for most drug manufacturers still provide its customers with nomograms, 
which is taken as the basis for this formula. Nomograms are printed in the 
standard text, which does not always accurately reproduce the original, which 
increases the risk to underestimate the surface area. A change in the BSA from 
1.87 to 1.60 m2 is equivalent to the weight loss of 22 kg for a woman with the 
weight of 80.5 kg and the height 158 cm. This means that it changes the dose of 
doxorubicin (50 mg/m2) from 93.5 mg to 80 mg.  
Drugs pharmacokinetics (PK) does not largely explain the variability of the 
BSA. Patientsʼ metabolism and the elimination of drugs vary. The same   Anthropometric measurements of the body composition ...  |  59 
chemotherapy dose among patients can give different effects. The body surface 
area does not take into account the pharmacokinetic processes caused by cyto-
toxic drugs. The given mathematical analysis of the weight is proportional to 
(correlate) the volume. This assumption is a valid argument for investigation.  
 
 
METHODS 
The study involved 202 patients, including 164 (81.2%) oncologic patients and 
38 (18.8%) control group patients. In the oncologic patient group there were 
93 (93.9%) men and 71 (68.9%) women. The control group consisted of 6 
(6.1%) men and 32 (31.1%) women. After the Pearson’s chi-square test of men 
and women groups statistically differed significantly (χ2 = 20.670, p <0.001). 
Also, the Fisher’s exact test shows that the null hypothesis probability is less 
than 0.001. 
 
Anthropometry:  Body anthropometric parameters in cancer patients were 
used as scales, measuring tapes, antropometers (gauge height) and calliper. 
The body volume was determined from the formulas using anthropometric 
measurement data.  
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Mediumbuild body tissue composition in relative terms (%):  
Gender  Adipose tissue mass Muscle mass Bone mass 
Male 12.63–16.29  32.91–35.18 10.77–12.88 
Female 19.60–24.21  23.69–25.64  8.64–9.61 
 
Different cultures and different times have different body compositions, and a 
body composition is also associated with health and sports performances. The 
body fat is epidemiologically sensitive to gender and age. [18] There are 
different recommendations for the ideal body fat percentage. It is designed by 
the American Council (not an official government agency) recommendations. 
(Table 1) 
 
Table 1. Aproximate relative amount of fat in the body of an adult. 
Description Female Male 
Essential fat  8–12%  3–5% 
Athletes 14–20%  6–13% 
Fitness 21–24%  14–17% 
“Average” 25–32%  18–24% 
Excess fat  32%+  25%+ 
 
Five formulas were used for calculating the BSA, ranked according to the 
RMSE Method of Prediction by Wang et al. (Table 2) 
 
Table 2. 
Autors  BSA (ĶVL) formula
Boyd
i BSA  (m
2) = Wt(kg)
0.4838 * Ht(cm)
0.3 * 0.017827 
Gehan and George  BSA (m
2) = Wt(kg)
0.51456 * Ht(cm)
0.42246 * 0.02350 
Mosteller  BSA (m
2) = [ Ht(cm) * Wt(kg) / 3600 ]
½ vai  
BSA (m
2) = [ Ht(in) * Wt(lbs) / 3131 ]
½ 
Haycock BSA  (m
2) = Wt(kg)
0.5378 * Ht(cm)
0.3964 * 0.024265 
Du Bois and Du Bois  BSA (m
2) = Wt(kg)
0.425 * Ht(cm)
0.725 * 0.007184   Anthropometric measurements of the body composition ...  |  61 
The Body volume was determined from the formulas using anthropometric 
measurement data. 
 
Statistical analysis: The study of statistical data analysis uses mathematical 
statistical methods to evaluate the measurements (length, thickness, circum-
ference and weight), the reliability and the relevance of the theoretical proba-
bility distributions, as well as to check the set of statistical hypotheses. So the 
work has very widely used common (popular) methods of descriptive statistics, 
which are described in many books, such as the books on statistics of biology 
and medicine [1, 15, 16]. The variables are measured on a relative scale and 
were normally distributed (Gaussian obeyed the law), were analyzed using 
parametric statistical methods. In other cases, the use of parametric statistical 
methods was done. Hypotheses on the data with a normal probability of distri-
bution is mainly tested in the Kolmogorov-Smirnovs test. Two-sample equal 
the arithmetical mean, using t-test. Three or more teams equal the arithmetical 
mean, for testing the analysis of variance (ANOVA) was used. ANOVA – 
English – Analysis of variance. A number of cases was used to compare the chi-
square test and the Fisher’s exact test. Relationship among different variables 
for the analysis and the prediction of events were calculated by using 
correlation and linear regression methods. Statistical data processing of a 
database to MS Excel, then conversion of the data to the professional study of 
statistical data processing (analysis) program SPSS (Statistical Package for 
Social Sciences) version 16.0 for Windows followed. All the hypothesis tests 
used the duplex (2-tailed) of statistical hypotheses and the null hypothesis was 
rejected if the probability (of relevance, significance level) was less than 5% or 
p <0.05. 
 
 
RESULTS 
Body Weight: In the  study it was important to determine the sample 
descriptive statistic indicators. The average weight of 99 men was   
78.5 ± 16.4 kg and the mean body weight of 103 women was 70.1 ± 14.6 kg. 
After the Lieven test sample distribution was statistically significantly different 
(F = 0.358, p = 0.551), but the independent-sample t-test arithmetical means 
differed statistically significantly (t = 3.839, p <0.001). The men’s average body 
weight was 59.9 passive ± 7.9 kg and the women’s average body mass was 
passive 46.6 ± 4.7 kg. After the Lieven test sample distribution statistically 62  |  A. Gerina-Berzina, U. Vikmanis, U. Teibe, S. Umbrashko 
differed significantly (F = 18.003, p <0.001) and independent samples t-test 
arithmetical means statistically differed significantly (t = 14.512, p <0.001). 
The men’s ideal average body weight was 70.9 ± 6.3 kg and the women’s 
average body mass of the passive was 55.9 ± 5.9 kg. After the Lieven test sample 
distribution was statistically significantly different (F = 1.123, p = 0.290), but 
the independent-sample t-test arithmetical means differed statistically 
significantly (t = 17.434, p <0.001). 
 
Patient’s height: Patient’s height (body length standing) ranged from 148.6 
to 192.5 cm, the average height – 169.6 ± 8.9 cm. Patient’s distribution 
according to height histograms and normal (Gaussian) distribution curve, 
where the average male’s height was 175.5 ± 6.9 cm and the females average 
height was 163.9 ± 6.6 cm (Figure 1). After the Lieven test sample distribution 
was statistically significantly different (F = 1.123, p = 0.290), but the indepen-
dent-sample t-test arithmetic means differed statistically significantly 
(t = 12.203, p <0.001). 
 
 
Figure 1. Patients with the absolute height distribution of the histogram and the normal 
(Gaussian) distribution curve. 
 
Body Mass Index: The men’s average body mass index was 25.41 ± 
4.73 kg/m2 and the women’s average body mass index was 26.20 ± 5.90 kg/m2. 
After the Lieven test sample distribution was statistically significantly different 
Body length (cm)
N
u
m
b
e
r
 
o
f
 
p
a
t
i
e
n
t
s
25
20
15
10
5
0
140,0     150,0       160,0           170,0         180,0          190,0   200,0  Anthropometric measurements of the body composition ...  |  63 
(F = 3.075, p = 0.081), and also by independent samples t-test arithmetical 
means was statistically significantly different (t = 1.043, p = 0.298).  
 
Table 3. Oncologic patients in the absolute and relative distribution of groups according to 
body mass index.  
BMI group  Number  %  Accrued % 
Light   23  11.4  11.4 
Ideal weight  98  48.5  59.9 
A little too heavy  17  8.4  68.3 
Heavier   33  16.3  84.7 
Obesity  31  15.3  100.0 
Together   202  100.0   
 
Oncologic patients in the absolute and relative distribution of groups according 
to the body mass index in relation to the patientʼs gender (Table 4). After the 
Pearson’s chi-square test of oncological patients in the absolute and relative 
distribution of groups according to body mass index in relation to the patientʼ 
gender differed statistically significantly (χ2 = 11.510, df = 4, p = 0.021). We 
can see that about half of men have the ideal weight (body mass), but only 
about 1/3 of women are with the ideal body weight. 
 
Table 4. Oncologic patients in the absolute and relative distribution of groups according to 
the body mass index in relation to the patient’s gender.  
BMI group  
Gender 
Together 
Male  Female 
Number  %  Number  %  Number  % 
Light   15  16.10  4  5.60  19  11.60 
Ideal weight  44  47.30  25  35.20  69  42.10 
A little too heavy   5  5.40  10  14.10  15  9.10 
Heavier   17  18.30  15  21.10  32  19.50 
Obesity   12  12.90  17  23.90  29  17.70 
Together   93  100.00  71  100.00  164  100.00 
 
Body surface area (BSA): The body surface area was used to calculate the 
methods described in five most popular formulas. The body surface area in the 
descriptive statistics is summarized (Table 5). The body surface area of the 
arithmetical mean and the standard deviations schedule of different methods of 
calculating the area are shown in Figure 2. 64  |  A. Gerina-Berzina, U. Vikmanis, U. Teibe, S. Umbrashko 
Table 5. Descriptive statistics of the body surface area calculation formula. 
BSA m
2  M  N  SD  m 
 Mosteller  1.88  164  0.22  0.01760 
 Du Bois & Du Bois  1.86  164  0.21  0.01618 
 Gehan and George  1. 90  164  0.23  0.01787 
 Boyd  1.91  164  0.24  0.01839 
 Haycock  1.90  164  0.24  0.01848 
 
 
 
 
Figure 2. Body surface area of the arithmetical mean and the standard deviations 
schedule of different methods of the calculating area.  
 
The relative comparison of different calculation methods for the body surface 
are given in relation to the patientʼs gender (Table 6). After using a variety of 
arithmetic formulas in the calculation of the BSA men’s differs less than 1% 
compared to the calculated area of the Mosteller formula. For women the 
difference is more than 1%. 
Among the body surface areas, calculated using different formulas there is a 
positive, strong and statistically significant (p <0.001) correlation. Calculated 
after Mosteller and Boyd formulas the body surface area of inter-
relationships between the points in the chart with gender (Figure 3).  
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Table 6. Body surface area, relative comparison of different calculation methods in 
relation to the patient’s gender.  
BSA of 
against Mostseller (%)  Gender  N  M  SD  m 
Gerhan George   Male  99  100.631  0.3305  9.0332 
Female  103  101.008  0.4394  0.0433 
Du Bois & Du Bois  Male  99  99.533  1.3932  0.1400 
Female  103  98.875  1.7374  0.1712 
Boyd   Male  99  100.693  0.9121  0.0917 
Female  103  101.576  1.2625  0.1244 
Haycock   Male  99  100.464  0.7220  0.0726 
Female  103  100.716  0.8755  0.0863 
 
Figure 3. Calculated after Mosteller and Boyd formulas the body surface area of the 
interrelationships between points graphs, the linear regression lines and their 95% 
confidencial interval limits in relation to the patient’s gender. 
Among the various calculated body surface areas there is a linear relationship 
(coefficient of determination r2 = 0.991). Since the analysis of variance 
(ANOVA) significance level areas interconnecting the p <0.001, then these 
fields are obtained using a linear combination. When the linear regression 
analysis was used, the equations, obtained by linear regression are: 
Male: 
BSA (Boyd), m2 = –0,078 +1,047× BSA (Mosteller), m2; 
Female: 
BSA (Boyd), m2 = –0,130 +1,090 × BSA (Mosteller), m2. 
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Body fat: The body fat calculation, using the body mass index, being put into 
practice by Deurenberg [3]. Correlations between densitometric body fat 
percentage (BF%) and BMI considering age and gender. Children and adults, 
body fat percentage calculated from different formulas:  
 
Body fat (for children)  
% = (1.51 × BMI) − (0.70 × age) − (3.6 × Gender) + 1.4; 
Body fat (for adults)  
% = (1.20 × BMI) + (0.23 × age) − (10.8 × Gender) – 5.4, 
* Gender = 1(for Male) 
Gender = 0 (for Female) 
 
The average body fat of oncologic patient’s percentage for men was 
27.3 ± 7.2% and 31.1 ± 9.7%. After the independent samples the t-test two 
sample arithmetical means differed statistically significantly (t = 8.105 and 
p<0.001). The distribution of patients in groups[18], the body fat content (%) 
of the patient shows that male and the female patients were primarily from the 
group with excessive fat in the body, the body fat for men is 25% or more of the 
total body weight, but that of women is over 32% of the total body weight. 
Calculated after the Mosteller formula the body surface area and the body fat 
interrelationships point graphically, the regression lines and their 95% confi-
dencial interval limits in relation to the patientsʼ gender appear (Figure 4). The 
correlation analysis showed that the body fat for men correlates with the body 
surface area, calculated using the Mosteller formula (r = 0.663, p<0.001) and 
the fat content for women correlates with the body surface area, calculated 
using the Mosteller formula (r = 0.760, p <0.001). We can see that outside the 
95% confidencial interval limits for men are 5 cases, but for women there are 
only 2 cases. 
 
The body volume: The body volume study enrolled the patients ranged from 
37.3 to 124.6 dm3 (liters). The oncologic patients body volume ranged from 
40.3 to 124.6 dm3 (liters). The body volume mean value was 72.2 ± 16.7 dm3. 
For all the men involved in the study the body volume the mean value was 
74.7 ±  16.7  dm3, the mean value of the female body volume was 66.2 ± 
14.9 dm3. After the independent samples t-test between men and women in the 
body volume, the arithmetical means differed statistically significantly 
(t = 3.839, p <0.001). For the male body volume the mean value was 75.0 ±   Anthropometric measurements of the body composition ...  |  67 
17.1 dm3, for the female body volume the mean value was 68.6 ± 15.6 dm3. 
After the independent samples t-test between men and women in the body 
volume, the arithmetical means differed statistically significantly (t = 2.437,  
p = 0.016) (Figure 5). 
 
Figure 4. Calculated after the Mosteller formula the body surface area and the body fat 
interrelationships point graphs, the regression lines and their 95% confidencial interval 
limits in relation to the patientsʼ gender.  
 
 
Figure 5. Calculated after the Mostsellera formula the body surface area and the body 
volume (in liters) and between points graphs, the linear regression lines and their 95% 
confidencial interval limits in relation to the patientsʼ gender.  
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DISCUSSION 
Anthropometric measurements are suitable for the calculation of the doses of 
chemotherapy, but taking into account the correlation it cannot be excluded 
that they reflect the same body surface area. The BMI does not feature the 
percentage of the fat mass of the whole body. Consequently, it is possible that 
the patient’s body density is a more physiological parameter, which could be 
determined for comparison by using abdominal computer tomography. The 
body volume index (BVI) could be one of the most recent parameters for the 
more accurate calculation of chemotherapy for cancer patients. The Body 
Volume Index (BVI) is a new measurement for human obesity that has been 
proposed as an alternative to the Body Mass Index (BMI). The BMI is based 
on a measurement of the total mass, irrespective of the location of the mass, but 
the BVI looks at the relationship between mass and volume distribution (i.e. 
where the body mass is located on the body). Recent studies have highlighted 
the limitations of the BMI as an indicator of the individual health risk [19,20]. 
The Body Volume Index (BVI) was originally devised in February 2000 as a 
new modern day measurement for measuring obesity; an alternative to the 
Body Mass Index (BMI) which was originally conceived between 1830 and 
1850. The BMI is based on height and weight only, but the new BVI system 
automatically measures the BMI, waist circumference and waist-hip ratio in 
addition to the highly sophisticated volumetric and body composition analysis. 
It is projected that scientific and technical development of the BVI may take a 
similar period to the BMI, so the year 2020 is the current projected date for 
adoption and delivery on the scale required. By 2012 there were 6 scientific and 
7 academic institutions involved in the evaluation and validation of the BVI as a 
potential new health risk measurement and indicator, which has been ongoing 
since March 2007. The BVI is an application [21] that can be used on a 3D Full 
Body Scanner to determine the individual health risk, whether the scanning 
hardware uses visible light optical information or otherwise. The BVI allows 
the differentiation between the people who are assigned the same BMI rating, 
but who have a different body shape and weight distribution, so that their 
individual BMI rating may not accurately reflect their own risk. The BVI has 
undergone clinical trials in the U.S. and Europe as part of a three year 
collaborative project, the Body Benchmark Study, the results of which were 
presented in October 2010 at a publicaly funded launch in Birmingham, the 
UK and scientific research and evaluation continuied in 2011 [22,23]. Whereas 
the BMI of a person is measured manually by total weight and height, the BVI   Anthropometric measurements of the body composition ...  |  69 
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distribution. The BVI measures where the weight and the fat are distributed on 
a person’s body, rather than the total weight or the total fat content. There has 
been an acceptance in recent years that abdominal fat and weight around the 
abdomen constitute a greater health risk[24], commonly known as central 
obesity. A full body surface scanner determines the three-dimensional outline 
of a person’s exterior surface, so that computation can be used to calculate the 
part volumes and the part body composition of that person. The BVI makes an 
inference as to the body’s distribution of weight and the distribution of muscle 
and fat, using complex and detailed Body Composition data[25]. Most 3D 
scanners suitable for the BVI require that the subject is scanned for a series of 
images under varying lighting conditions (various projected patterns), to 
determine the body shape and weight distribution data for the individual 
patient and the statistical analysis and the BVI is currently under evaluation by 
government agencies in the UK as a possible long-term replacement for the 
BMI. The BVI was conceived as a potential replacement for the BMI at the 
turn of the millennium and after preliminary development, initial validation 
was undertaken by the Heartlands Hospital, a NHS Obesity Centre in the UK. 
This was followed by clinical testing in the US by the Mayo Clinic in 
Rochester, Minnesota[26]. An initial pilot study highlighted the potential of 
the BVI as a motivational tool for the weight loss in patients and as part of the 
Body Benchmark Study, a recent further study aimed to assess the validity and 
reproductibility of the BVI scanner in measuring the anthropometric markers 
of obesity[22,27]. Comparative validation of the reliability of automatic 
measurement as opposed to manual measurement concluded that the scanner 
is a reliable, valid and reproducible method to measure waist and hip circum-
ferences[27]. Ongoing developments in 2012 include initial benchmarking of 
the BVI values for children aged 4–17 and the collation of 3D data in the US 
and Europe for use as normative data for the BVI in male and female adults. 
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